Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | KDM5A | P29375 | 3/20 | 0.48 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9807773 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL10606558 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL1003342 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL516699 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL236922 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL24028136 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL14840251 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL2945945 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL21409651 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL4891747 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5710307-A | Process for the production of trialkyl phosphites | BAYER AG (DE) | 1998-01-20 | — | — | US | claimed |
| US-4430513-A | COBALT OR RHODIUM CARBONYL, CARBON-CARBON BOND FORMATION | UOP INC. (US) | 1984-02-07 | — | — | US | claimed |
| JP-60048144-A | — | — | None | — | — | JP | disclosed |
| JP-60212232-A | — | — | None | — | — | JP | disclosed |
| EP-3878838-B1 | POLYISOCYANATE COMPOSITION, COATING COMPOSITION AND COATED SUBSTRATE | ASAHI CHEMICAL IND (JP) | 2025-07-23 | — | — | EP | disclosed |
| US-20250122322-A1 | ZWITTERIONIC COMPOUND, AND BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANATE COMPOSITION CONTAINING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR MANUFACTURING SAME, AND CARBONATE COMPOUND | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-04-17 | — | — | US | disclosed |
| US-12077631-B2 | Bulk polymerisation of polyoxazolidone | BASF SE (DE) | 2024-09-03 | — | — | US | disclosed |
| CN-117769574-A | Zwitterionic compound, blocked isocyanate blocking agent dissociation catalyst, blocked isocyanate composition containing same, thermosetting resin composition, cured product, preparation method of cured product, and carbonate compound | 广荣化学株式会社 | 2024-03-26 | — | — | CN | disclosed |
| EP-4332137-A1 | BASE COATING COMPOSITION, MULTILAYER COATING FILM LAMINATE, AND METHOD FOR FORMING MULTILAYER COATING FILM LAMINATE | Asahi Kasei Kabushiki Kaisha (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-117645828-A | Coating composition for substrate, multilayer coating film laminate, and method for forming multilayer coating film laminate | 旭化成株式会社 | 2024-03-05 | — | — | CN | disclosed |
| EP-4210883-B1 | INVESTMENT CASTING COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-02-14 | — | — | EP | disclosed |
| US-4251092-A | COATED WITH A 3-HETERO-3-(DIPHENYLAMINO)PHTHALIDES COLOR FORMER | STERLING DRUG INC. (US) | 1981-02-17 | — | — | US | disclosed |
| US-4251446-A | COLOR PRECURSORS | STERLING DRUG INC. (US) | 1981-02-17 | — | — | US | disclosed |
| US-4250115-A | Preparation of tertiary amines | UOP INC. (US) | 1981-02-10 | — | — | US | disclosed |
| US-4207260-A | Preparation of tertiary amines | UOP INC. (US) | 1980-06-10 | — | — | US | disclosed |
| US-4200313-A | Carbonless duplicating systems | STERLING DRUG INC. (US) | 1980-04-29 | — | — | US | disclosed |
| US-4189171-A | PRESSURE SENSITIVE, THERMAL AND HECTOGRAPHIC SYSTEMS | STERLING DRUG INC. (US) | 1980-02-19 | — | — | US | disclosed |
| US-4187223-A | 3-[4-(Disubstituted-amino)phenyl]-3-(diphenylamino)phthalides | STERLING DRUG INC. (US) | 1980-02-05 | — | — | US | disclosed |
| US-4182714-A | CARBONLESS COLORING DUPLICATING | STERLING DRUG INC. (US) | 1980-01-08 | — | — | US | disclosed |
| US-4168378-A | THERMOGRAPHY, LEUCO DYES | STERLING DRUG INC. (US) | 1979-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122322-A1 | ZWITTERIONIC COMPOUND, AND BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANATE COMPOSITION CONTAINING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR MANUFACTURING SAME, AND CARBONATE COMPOUND | RCC1, KDM2B, RB1 | DNM1 2005/4885TSHR 4434/4885THRB 3913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.